All terms in NCIT
| Label | Id | Description |
|---|---|---|
| FGFR2 NP_000132.3:p.P253R | NCIT_C107591 | [A change in the amino acid residue at position 253 in the fibroblast growth factor receptor 2 protein where proline has been replaced by arginine.] |
| Submental Lymph Node Group (Sublevel IA) | NCIT_C132508 | [Lymph nodes within the triangular boundary of the anterior belly of the digastric muscles and the hyoid bone. These nodes are at greatest risk for harboring metastases from cancers arising from the floor of mouth, anterior oral tongue, anterior mandibular alveolar ridge, and lower lip. (AJCC 8th ed.)] |
| FGFR2 NM_000141.4:c.1115C>G | NCIT_C107592 | [A nucleotide substitution at position 1115 of the coding sequence of the FGFR2 gene where cytosine has been mutated to guanine.] |
| FGFR2 NP_000132.3:p.S372C | NCIT_C107593 | [A change in the amino acid residue at position 372 in the fibroblast growth factor receptor 2 protein where serine has been replaced by cysteine.] |
| Submandibular Lymph Node Group (Sublevel IB) | NCIT_C132509 | [Lymph nodes within the boundaries of the anterior and posterior bellies of the digastric muscle, the stylohyoid muscle, and the body of the mandible. These include the preglandular and the postglandular nodes and the prevascular and postvascular nodes. The submandibular gland is included in the specimen when the lymph nodes within the triangle are removed. These nodes are at greatest risk for harboring metastases from cancers arising from the oral cavity, anterior nasal cavity, skin, and soft tissue structures of the midface, as well as from the submandibular gland. (AJCC 8th ed.)] |
| FGFR2 NM_000141.4:c.1124A>G | NCIT_C107594 | [A nucleotide substitution at position 1124 of the coding sequence of the FGFR2 gene where adenine has been mutated to guanine.] |
| FGFR2 NP_000132.3:p.Y375C | NCIT_C107595 | [A change in the amino acid residue at position 375 in the fibroblast growth factor receptor 2 protein where tyrosine has been replaced by cysteine.] |
| FGFR2 NM_000141.4:c.1144T>C | NCIT_C107596 | [A nucleotide substitution at position 1144 of the coding sequence of the FGFR2 gene where thymine has been mutated to cytosine.] |
| FGFR2 NP_000132.3:p.C382R | NCIT_C107597 | [A change in the amino acid residue at position 382 in the fibroblast growth factor receptor 2 protein where cysteine has been replaced by arginine.] |
| Failure to Thrive | NCIT_C107587 | [A clinical finding indicating less than normal growth in an infant or child, or a state of global decline in an adult.] |
| Finding by Cause | NCIT_C36291 | |
| CDISC Questionnaire EPDS Test Code Terminology | NCIT_C132521 | [Test codes of questionnaire questions associated with the Edinburgh Postnatal Depression Scale (EPDS) for the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).] |
| Interleukin-8 Receptor | NCIT_C107588 | [A family of chemokine receptors that specifically bind to interleukin-8 and play a role in G-protein-coupled receptor-mediated signal transduction.] |
| CDISC Questionnaire HAQ-DI Without VAS Test Name Terminology | NCIT_C132522 | [Test names of questionnaire questions associated with the Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale (HAQ-DI Without VAS) for the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).] |
| Chemokine Receptor Antagonist | NCIT_C63817 | [Any agent that binds to and blocks any of the chemokine receptor subtypes. Chemokine receptors, members of the G-protein coupled receptor family, are predominantly expressed on the surface of leukocytes and play an important role in inflammation, infectious diseases, and cancer.] |
| CDISC Questionnaire HAQ-DI Without VAS Test Code Terminology | NCIT_C132523 | [Test codes of questionnaire questions associated with the Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale (HAQ-DI Without VAS) for the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).] |
| CDISC Questionnaire TSQM Version 1.4 Test Name Terminology | NCIT_C132524 | [Test names of questionnaire questions associated with the Treatment Satisfaction Questionnaire for Medication Version 1.4 (TSQM Version 1.4) for the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).] |
| CDISC Questionnaire TSQM Version 1.4 Test Code Terminology | NCIT_C132525 | [Test codes of questionnaire questions associated with the Treatment Satisfaction Questionnaire for Medication Version 1.4 (TSQM Version 1.4) for the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).] |
| HMGB1 Gene | NCIT_C20578 | [This gene plays a role in chromatin remodeling, signal transduction and the regulation of gene transcription. It is also involved in the pro-inflammatory response.] |
| HMGB Family Gene | NCIT_C20574 | [Human HMGB Family Genes encode abundant DNA-binding and bending HMG-Box Family proteins (with structure, rather than sequence, specificity) that play an architectural role in nucleoprotein assembly. They have two homologous DNA-binding HMG-box domains connected by a short basic linker to an acidic C-terminus that differs in length. Tail length may be the dominant factor mediating property differences among HMGB proteins and determines DNA-binding properties of the HMG boxes. The tail is essential for DNA-binding. (NCI)] |